IDiyas

For the Inventor, By the Inventor

North Andover, MA, United States of America

Syed M Ali

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 77(Granted Patents)


Location History:

  • Lynchburg, VA (US) (2012)
  • North Andover, MA (US) (2009 - 2013)

Company Filing History:

goldMedal17 out of 104 
 
Arqule, Inc.
 patents
silverMedal1 out of 120 
 
Tdw Delaware, Inc.
 patents

Years Active: 2009-2013

where 'Filed Patents' based on already Granted Patents

18 patents (USPTO):
1. 8563567 - Substituted heterocyclic compounds (2013-10-22),
2. 8541407 - Substituted benzo-pyrido-triazolo-diazepine compounds (2013-09-24),
3. 8513292 - Compositions and methods for the treatment of cancer (2013-08-20),
4. 8357694 - Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds (2013-01-22),
5. 8343977 - Substituted triazolo-pyrimidine compounds (2013-01-01),
6. 8319494 - Pipeline inspection tool with double spiral EMAT sensor array (2012-11-27),
7. 8304425 - Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer (2012-11-06),
8. 8273754 - Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds (2012-09-25),
9. 8263610 - Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds (2012-09-11),
10. 8232285 - Quinazolinone compounds and methods of use thereof (2012-07-31),
11. 8114873 - 1,4-disubstituted naphthalenes as inhibitors of p38 map kinase (2012-02-14),
12. 8067459 - Lapachone compounds and methods of use thereof (2011-11-29),
13. 8039503 - Lapachone compounds and methods of use thereof (2011-10-18),
14. 7932279 - Substituted tetrazole compounds and uses thereof (2011-04-26),
15. 7902354 - Lapachone compounds and methods of use thereof (2011-03-08),

Title: Syed M Ali: Innovator in Pharmaceutical Compounds

Introduction

Syed M Ali is a prominent inventor based in North Andover, MA, with a remarkable portfolio of 18 patents. His work primarily focuses on the development of pharmaceutical compounds aimed at treating cell proliferative disorders, including cancer. His innovative contributions have significantly impacted the field of medicinal chemistry.

Latest Patents

Among his latest patents, Syed M Ali has developed substituted heterocyclic compounds. This invention relates to methods of synthesizing these compounds and pharmaceutical compositions that contain them. These compounds are designed to treat cell proliferative disorders, such as cancer, by administering them to subjects in need. Another notable patent involves substituted benzo-pyrido-triazolo-diazepine compounds. Similar to his previous work, this invention also focuses on methods of synthesis and pharmaceutical applications for treating cancer.

Career Highlights

Throughout his career, Syed M Ali has worked with notable companies, including Arqule, Inc. and Tdw Delaware, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovation and contribute to significant advancements in the field.

Collaborations

Syed M Ali has collaborated with esteemed professionals in his field, including Mark Anthony Ashwell and Manish Tandon. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Syed M Ali's contributions to the field of pharmaceutical compounds demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a key figure in the fight against cancer and other cell proliferative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…